Baseline clinical characteristics and medical therapy during hospitalization of AKI versus non-AKI patients according to the two AKI criteria used.

Continuous variables are presented as medians (with interquartile ranges), and categorical variables are presented as percentages. AKI, acute kidney injury; RIFLE, Risk, Injury, Failure, Loss, and End-stage kidney Disease; KDIGO, Kidney Disease: Improving Global Outcomes; HTN, hypertension; HCL, hypercholesterolemia; EVD, extracardiac vascular disease; CAD, coronary artery disease; CABG, coronary artery bypass graft; ACEIs, angiotensin-converting enzyme inhibitors; ARBs, angiotensin II receptor blockers; STEMI, ST-segment elevation myocardial infarction; SBP, systolic blood pressure; HR, heart rate; SCr, serum creatinine; eGFR, estimated glomerular filtration rate; PCI, percutaneous coronary intervention; LVD, left ventricular dysfunction.*n = 1049;†n = 1040;‡n = 518 (only for STEMI patients);§Primary or non-primary;||with PCI or thrombolytics;#n = 9.